Healthcare provider profile · identity verified

Marcus Elijah Babaoff, M.D.

Family Practice · ELON, NC · NPI 1861650590

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	630	181
Simvastatin	Simvastatin	358	98
Amlodipine Besylate	Amlodipine Besylate	350	98
Levothyroxine Sodium	Levothyroxine Sodium	350	87
Losartan Potassium	Losartan Potassium	319	98
Omeprazole	Omeprazole	309	90
Pantoprazole Sodium	Pantoprazole Sodium	300	81
Fluticasone Propionate	Fluticasone Propionate	260	94
Metformin Hcl Er	Metformin Hcl	252	70
Rosuvastatin Calcium	Rosuvastatin Calcium	240	66
Montelukast Sodium	Montelukast Sodium	226	74
Hydrochlorothiazide	Hydrochlorothiazide	215	60
Citalopram Hbr	Citalopram Hydrobromide	208	59
Metoprolol Succinate	Metoprolol Succinate	201	55
Trazodone Hcl	Trazodone Hcl	199	58
Glipizide Er	Glipizide	194	53
Tamsulosin Hcl	Tamsulosin Hcl	167	48
Bupropion Xl	Bupropion Hcl	166	58
Gabapentin	Gabapentin	164	56
Lisinopril	Lisinopril	155	50
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	151	44
Atenolol	Atenolol	145	43
Prednisone	Prednisone	144	110
Escitalopram Oxalate	Escitalopram Oxalate	142	43
Duloxetine Hcl	Duloxetine Hcl	141	39
Meloxicam	Meloxicam	129	53
Finasteride	Finasteride	124	36
Alprazolam	Alprazolam	120	25
Metformin Hcl	Metformin Hcl	112	32
Ezetimibe	Ezetimibe	108	31
Eliquis	Apixaban	107	22
Venlafaxine Hcl Er	Venlafaxine Hcl	104	21
Clopidogrel	Clopidogrel Bisulfate	101	32
Pravastatin Sodium	Pravastatin Sodium	99	23
Famotidine	Famotidine	97	23
Allopurinol	Allopurinol	95	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	94	26
Furosemide	Furosemide	90	30
Metoprolol Tartrate	Metoprolol Tartrate	82	22
Sertraline Hcl	Sertraline Hcl	80	24
Albuterol Sulfate Hfa	Albuterol Sulfate	79	38
Tramadol Hcl	Tramadol Hcl	78	21
Ozempic	Semaglutide	68	13
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	63	19
Carvedilol	Carvedilol	59	18
Olmesartan Medoxomil	Olmesartan Medoxomil	59	15
Telmisartan	Telmisartan	59	21
Zolpidem Tartrate	Zolpidem Tartrate	54	13
Jardiance	Empagliflozin	48	11
Mirtazapine	Mirtazapine	47	17
Pioglitazone Hcl	Pioglitazone Hcl	46	15
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	45	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	40	14
Lovastatin	Lovastatin	37	suppressed
Benazepril Hcl	Benazepril Hcl	35	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	35	29
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Lorazepam	Lorazepam	34	11
Spironolactone	Spironolactone	34	13
Triamcinolone Acetonide	Triamcinolone Acetonide	34	13
Ibandronate Sodium	Ibandronate Sodium	33	14
Azelastine Hcl	Azelastine Hcl	32	suppressed
Pregabalin	Pregabalin	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	13
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Valsartan	Valsartan	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Azithromycin	Azithromycin	25	24
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Potassium Chloride	Potassium Chloride	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Ramipril	Ramipril	23	suppressed
Glipizide	Glipizide	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	21
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	21	suppressed
Cephalexin	Cephalexin	21	19
Divalproex Sodium Er	Divalproex Sodium	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Dutasteride	Dutasteride	20	suppressed
Raloxifene Hcl	Raloxifene Hcl	20	suppressed
Methocarbamol	Methocarbamol	19	14
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Nabumetone	Nabumetone	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Ondansetron Odt	Ondansetron	15	12
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Galantamine Hbr	Galantamine Hbr	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Estradiol	Estradiol	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Colchicine	Colchicine	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Tiadylt Er	Diltiazem Hcl	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	11	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Topiramate	Topiramate	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error